 | • レポートコード：MRC2106A400 • 出版社/出版日：Mordor Intelligence / 2021年5月30日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は、世界のキトサン市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、原料別（小エビ、エビ、カニ、その他）分析、用途別（水管理、化粧品、製薬・生体医療、食品・飲料、その他）分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のキトサン市場規模：原料別（小エビ、エビ、カニ、その他） ・世界のキトサン市場規模：用途別（水管理、化粧品、製薬・生体医療、食品・飲料、その他） ・世界のキトサン市場規模：地域別 ・競争状況 ・市場機会/将来の見通し |
The Global Chitosan Market is expected to register a CAGR of 21.3% over the forecast period.
Globally, the researchers showing interest in the use of Chitosan in the pharmaceutical and biomedical fields as a potential agent for the prevention and treatment of infectious diseases. In December 2019, China became the epicenter of the SARS-CoV-2 outbreak, which has since spread internationally. In 2020, the World Health Organization (WHO) declared COVID-19 to be a global health emergency. Countering the impacts of viral disease outbreaks such as COVID-19 required research and development activities by researchers across the globe. Thus, the COVID-19 outbreak is likely to show a positive impact on market growth because the application of chitosan polymers as viral inhibitors will generate key growth opportunities in near future.
Furthermore, biopolymers, such as chitosan have intrinsic antiviral properties. Nanostructured drug-delivery systems (NDDS) based carbohydrate-binding agents, such as the sulfated polymers, can also change the virus entry process, blocking the viral cationic surface receptors and avoiding its interaction with heparan sulfate proteoglycan on the host cell surface. However, there are no reports of NDDS as COVID-19 treatment so far. It can be a new approach for COVID-19 treatment in near future.
The other factors that are driving the market growth include growing product application in biomedical, cosmetics and food and beverage industries, rising water treatment activities worldwide and strong advancements in the healthcare/medical industry in developed countries.
Chitosan composed systems utilize the characteristics of chitosan to achieve great therapeutic effects. For instance, the adhesiveness of chitosan can be used for non-invasive mucosal vaccine vectors. Therefore, chitosan-composed systems have great potential in the therapy of infectious diseases.
Chitosan is a natural polysaccharide that exhibits properties such as biodegradability, non-toxicity, biocompatibility, hemostatic and bio-adhesiveness and penetration enhancing properties. Moreover, it has anti-microbial properties
As per National Center for Biotechnology Information (NCBI), deacetylated chitosan is a vital additive in filtration and water treatment which eliminates 99% of turbidity. Moreover, chitosan is an easily available product extracted from a waste product in fishery industry with several uses in other industries such as wound care material in pharmaceutical industries, acts as a natural flavor and used to control moisture in food industries leading to high demand of these polymer and further boost the overall market.
Furthermore, as stringent government regulations are forcing manufactures to reduce plastic bag results in the growing demand for biodegradable plastic where chitin is being widely used. This led to the increasing adoption of chitosan and further drive the market growth over the forecast period.
Key Market Trends
Under Application Water Treatment is Expected to Witness a Healthy Growth Rate Over the Forecast Period
Water treatment is expected to witness healthy growth in the future attributing to the growing demand of chitosan in industries, commercial and municipal water treatment plants. Several advantages such as the ability to remove pesticides, surfactants, and phenol from the water making it highly preferable in water treatment plants. Increasing demand for chitosan as a water cleaner because of its non-toxic, non-allergic biodegradable nature will also be leading to propel the segment growth.
The presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in water and wastewater has recently been reported. The stools and masks of the COVID-19 patients were considered as the primary route of coronavirus transmission into water and wastewater.
For instance, according to a research article by Hai Nguyen Tran et al., published in Environmental Research Journal 2021, study confirmed that SARS-CoV-2 RNA was detected in inflow wastewater. Although the existence of SARS-CoV-2 in water influents has been confirmed. Therefore, in future studies should focus on the survival of SARS-CoV-2 in water and wastewater under different operational conditions and whether the transmission from COVID-19-contaminated water to human is an emerging concern. Thus, use of chitosan for water treatment in near future is expected to encourgae to prevent viral diseases like COVID-19.
Furthermore, the chitosan is a good flocculant for tap water treatment due to properties such as faster deposition rate and higher removal efficiency for COD (organic matter), metal ions and SS (suspended solids). Moreover, as countries around the globe emphasize wastewater treatment to minimize pollution, chitosan demand will continue to increase in coming years.
Depleting ground water level and rapidly growing urban population in Asia Pacific countries have resulted in the acute scarcity of usable fresh water. This has led to investments by governments and private players in water treatments mainly in India, China and Malaysia.
For instance, in India, during 2012-2017 period, Indian planning commission has budgeted around USD 26.5 billion for providing safe water to all urban and rural Indians. Treatment of sewage, waste water treatment and solid, liquid and chemical waste, water technology, environmental services, desalination companies, consulting and engineering are some services that India will require to tackle the water problem.
In addition, in 2019, the government of India with the Bhabha Atomic Research Centre (BARC) planned for installing water filtration plants in villages. The the government’s target to provide clean drinking water to all by 2024. Thus, owing to above mentioned factors it is expected to drive segment growth over the forcast period.
North America is Expected to Hold a Significant Share in the Market Over the Forcasted Period
North America is expected to hold a signifcant market share in the global Chitosan Market due to increasing awareness regarding water treatment, growing demand for cosmetics in the United States with the presence of major players in this region. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
The COVID-19 pandemic has shown positive response towards Chitosan Market as chitosan based research and development has been increasing in the development of therapeutics or protective equipments in the management of the disease. In 2021, a clinical studies has been conducting to investigate the protective effect of a new type of respirator with a filter element containing chitosan nanoparticles which shows positive impact on the market.
Increasing obesity and overweight issues in the region and rising health awareness among people act as a significant opportunity for the chitosan market. For instance, obesity is one of the major population health issue in Canada, which is affecting one in five Canadian adults as per the Canadian Institute for Health Information. Seven million Canadians are living with obesity according to a 2017 Canadian Obesity Network report.
The Asia Pacific is also expected to grow at a healthy growth in the forecasted period owing to rapid development of end-use industries in Japan, China, India, and South Korea. With the Increasing demand for biobased products coupled with a supportive government, initiatives will also boost the chitosan market.
One of the key factors driving the chitosan demand in the Asia Pacific region is the easy availability of its raw material, obtained as a waste product from the fishery industry. For instance, according to the Food and Agriculture Organization of the United Nations, during the first half of 2019, the China imported 285,900 tons of shrimp mainly from Ecuador, India, and Saudi Arabia, which was 186% more compared to 100,000 tons imported in 2018. Thus, owing to above mentioned factors it is expected to drive market growth.
Competitive Landscape
The Chitosan Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market Panvo Organics Pvt., Ltd, GTC Bio Corporation, Dupont Corporation, KitoZyme S.A., KIMICA Corporation, Dainichiseika Color & Chemicals Mfg. Co. Ltd, Heppe Medical Chitosan GmbH, Meron Biopolymers, Qingdao Yunzhou and Biophrame Technologies.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Water Treatment Activities
4.2.2 Growing Product Application in Biomedical, Cosmetics and Food and Beverage Industries
4.2.3 Strong Advancements in Healthcare/Medical Industry
4.3 Market Restraints
4.3.1 Regulatory Framework
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Source
5.1.1 Shrimps
5.1.2 Prawns
5.1.3 Crabs
5.1.4 Other Sources
5.2 By Application
5.2.1 Water treatment
5.2.2 Cosmetics
5.2.3 Pharmaceutical and biomedical
5.2.4 Food and beverage
5.2.5 Other applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Panvo Organics Pvt., Ltd.
6.1.2 GTC Bio Corporation
6.1.3 Dupont Corporation
6.1.4 KitoZyme S.A.
6.1.5 KIMICA Corporation
6.1.6 Dainichiseika Color & Chemicals Mfg. Co. Ltd
6.1.7 Heppe Medical Chitosan GmbH
6.1.8 Meron Biopolymers
6.1.9 Qingdao Yunzhou
6.1.10 Biophrame Technologies
6.1.11 ChitoTech
6.1.12 Marshal Marine
6.1.13 BIO21 Co., Ltd.
6.1.14 Austanz Chitin Pty Ltd
6.1.15 KiOmed Pharma
7 MARKET OPPORTUNITIES AND FUTURE TRENDS